Rituximab and Belimumab for Lupus Nephritis
Clinical trial NCT02260934 · COMPLETED
Trial details
- NCT number
- NCT02260934
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-09
- Primary completion
- 2018-03-12
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.